Receive monthly emails about the latest oncology research and technology, new patient services, resources and more!

Please select an option below to help us tailor your newsletter to best suit your content interests!

No thanks

ASCO 2021: Abstract Recommendations From Dr. Ari VanderWalde for Melanoma

Posted by & filed under Uncategorized.

Oral Abstract Session: Melanoma/Skin Cancers Sunday, June 6, 2021; 8:00 AM–11:00 AM EDT 9501 Final analysis of overall survival (OS) and relapse-free-survival (RFS) in the intergroup S1404 phase III randomized trial comparing either high-dose interferon (HDI) or ipilimumab to pembrolizumab in patients with high-risk resected melanoma. KF Grossmann, M Othus, SP Patel, et al Take-Home Message The… Read more »

First in the Region to Offer MRI-Guided Brachytherapy for Cervical Cancer

Posted by & filed under Uncategorized.

New technology and treatments for cancer are ever changing. Researching and providing innovative, curative therapies are a top priority at West Cancer Center. Now women managing cervical cancer will have access to MRI-guided brachytherapy treatment as an option – first available in the MidSouth, right here at West. According to the American Cancer Society, cervical… Read more »

West Physicians Present at ASCO Annual Meeting

Posted by & filed under Uncategorized.

Our West family is proud to have several of our oncologists publish research being presented at the upcoming American Society of Clinical Oncology Meeting, taking place June 4 – 8. West Cancer Center doctors Schwartzberg, Grothey, A. VanderWalde, Vaena, Vidal and ElNaggar are some of the renowned physicians being recognized at this esteemed event for… Read more »

OneR and West Cancer Physicians Give Ten Presentations at SABCS

Posted by & filed under Uncategorized.

OneR and West Cancer Physicians Give Ten Presentations at SABCS   OneOncology, the national network of independent oncology practices, announced today that physicians from OneR, the OneOncology Research Network and West Cancer and Research Institute will share results from ten research studies at the San Antonio Breast Cancer Symposium® (SABCS®), an international gathering of physicians and… Read more »

Choosing the Right Biosimilar for Cancer Care

Posted by & filed under Approved.

Choosing the Right Biosimilar for Cancer Care   The introduction of biosimilars as anticancer therapies was preceded by a period of supportive care biosimilars. Lee S. Schwartzberg, MD, FACP, describes how he and other clinicians decide which of these agents to use.   Well before biosimilar anticancer agents became available, oncologists gained familiarity using biosimilars… Read more »

X